Glaukos. Dedicated to Transforming Glaucoma Therapy.

Glaukos is an ophthalmic medical technology company focused on the development and commercialisation of breakthrough global technologies designed to transform the treatment of elevated eye pressure associated with glaucoma, one of the world’s leading causes of blindness. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionise the traditional glaucoma treatment and management paradigm. At Glaukos, our foundation is strong, our commitment is clear, and we are steadfast in our goal to transform glaucoma therapy.

Since our founding in 1998, we have dedicated the full strength of our resources, talents, and energy toward a single goal: to enrich the lives of glaucoma patients worldwide by establishing new ways to effectively manage intraocular pressure.

This unwavering focus on overcoming the challenges of traditional glaucoma therapy sets Glaukos apart in the global ophthalmic marketplace. We are the glaucoma-centric company, and proud to be the industry pioneer, founder, and leader of Micro-Invasive Glaucoma Surgery, or MIGS.

Our Mission

Our mission is to pioneer and lead the global glaucoma market with micro-scale injectable therapies that advance the existing glaucoma standard-of-care and enrich the lives and treatment alternatives for glaucoma patients worldwide.

See Glaucoma in a New Light.

If you’ve been diagnosed with glaucoma, don’t get discouraged. Get informed. Learn about your condition and understand just how much you still have to look forward to.

Learn More About Glaucoma

Speak with a Surgeon Today

Eye professionals offer treatment and control of eye pressure associated with mild-to-moderate primary open-angle glaucoma, and are available to answer your questions. Talk with a surgeon in your area today.

Find a Surgeon
Glaukos is excited to announce that we have acquired Avedro, Inc.!